SEARCH

SEARCH BY CITATION

References

  • Andersen J. K. (2001) Does neuronal loss in Parkinson's disease involve programmed cell death? Bioessays 23, 640646.
  • Bellacosa A., Chan T. O., Ahmed N. N., Datta K., Malstrom S., Stokoe D., McCormick F., Feng J. N. and Tsichlis P. (1998) Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313325.
  • Bensadoun J. C., Deglon N., Tseng J. L., Ridet J. L., Zurn A. D. and Aebischer P. (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF. Exp. Neurol. 164, 1524.
  • De Bernardo S., Canals S., Casarejos M. J., Solano R. M., Menendez J. and Mena M. A. (2004) Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures. J. Neurochem. 91, 667682.
  • Brines M. L., Ghezzi P., Keenan S., Agnello D., De Lanerolle N. C., Cerami C., Itri L. M. and Cerami A. (2000) Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury. Proc. Natl Acad. Sci. USA 97, 10 52610 531.
  • Burgering B. M. T. and Coffer P. J. (1995) Protein kinase-B (C-Akt) in phosphatidylinositol-3-Oh Kinase signal transduction. Nature 376, 599602.
  • Byrd J. C. and Alho H. (1987) Differentiation of PC12 pheochromocytoma cells by sodium butyrate. Brain Res 428, 151155.
  • Cardone M., Roy N., Stennicke H., Stanbridge E., Franke T., Salvesen G. and Reed J. (1998) Regulation of cell death protease caspase-9 by Akt-mediated protein phosphorylation. Mol. Biol. Cell 9, 246a246a.
  • Chavez J. C. and LaManna J. C. (2002) Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1. J. Neurosci. 22, 89228931.
  • Chen G., Bower K. A., Ma C. L., Fang S. Y., Thiele C. J. and Luo J. (2004) Glycogen synthase kinase 3 beta (GSK3 beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. 18, 11621164.
  • Chen J., Nagayama T., Jin K., Stetler R. A., Zhu R. L., Graham S. H. and Simon R. P. (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18, 49144928.
  • Chong Z. Z., Kang J. Q. and Maiese K. (2002) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab. 22, 503514.
  • Chong Z. Z., Kang J. Q. and Maiese K. (2003a) Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1 and Bad, caspase-mediated pathways. Br. J. Pharmacol. 138, 11071118.
  • Chong Z. Z., Lin S. H., Kang J. Q. and Maiese K. (2003b) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, 8. J. Neurosci. Res. 71, 659669.
  • Cowen T. (2002) Selective vulnerability in adult and ageing mammalian neurons. Auton. Neurosci. 96, 2024.
  • Cross D. A. E., Alessi D. R., Cohen P., Andjelkovich M. and Hemmings B. A. (1995) Inhibition of glycogen-synthase kinase-3 by insulin mediated by protein-kinase-B. Nature 378, 785789.
  • Csete M., Rodriguez L., Wilcox M. and Chadalavada S. (2004) Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts. Neurosci. Lett. 359, 124126.
  • Datta S. R., Dudek H., Tao X., Masters S., Fu H. A., Gotoh Y. and Greenberg M. E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231241.
  • Defazio G., Soleo L., Zefferino R. and Livrea P. (1996) Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture. Brain Res. Bull. 40, 257262.
  • Digicaylioglu M. and Lipton S. A. (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signaling cascades. Nature 412, 641647.
  • Digicaylioglu M., Bichet S., Marti H. H., Wenger R. H., Rivas L. A., Bauer C. and Gassmann M. (1995) Localization of specific erythropoietin binding-sites in defined areas of the mouse-brain. Proc. Natl Acad. Sci. USA 92, 37173720.
  • Ding Y. M., Jaumotte J. D., Signore A. P. and Zigmond M. J. (2004) Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J. Neurochem. 89, 776787.
  • Dirnagl U., Simon R. P. and Hallenbeck J. M. (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248254.
  • Dolcet X., Soler R. M., Gould T. W., Egea J., Oppenheim R. W. and Comella J. X. (2001) Cytokines promote motoneuron survival through the janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Mol. Cell Neurosci. 18, 619631.
  • Dodel R. C., Du Y., Bales K. R., Ling Z., Carvey P. M. and Paul S. M. (1999) Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Brain Res. Mol. Brain Res. 64, 141148.
  • Ehrenreich H., Hasselblatt M., Dembowski C. et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495505.
  • Erbayraktar S., Grasso G., Sfacteria A. et al. (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc. Natl Acad. Sci. USA 100, 67416746.
  • Genc S., Kuralay F., Genc K., Akhisaroglu M., Fadiloglu S., Yorukoglu K., Fadiloglu M. and Gure A. (2001) Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production. Neurosci. Lett. 298, 139141.
  • Hagg T. and Varon S. (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl Acad. Sci. USA 90, 63156319.
  • Han B. S., Noh J. S., Gwag B. J. and Oh Y. J. (2003) A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau. Neurosci. Lett. 341, 99102.
  • He T. C., Zhou S. B., Da Costa L. T., Yu J., Kinzler K. W. and Vogelstein B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95, 25092514.
  • Hu P., Han Z., Couvillon A. D. and Exton J. H. (2004) Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J. Biol. Chem. 279, 49 42049 429.
  • Kawakami M., Sekiguchi M., Sato K., Kozaki S. and Takahashi M. (2001) Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276, 39 46939 475.
  • Kilic U., Kilic E., Soliz J., Bassetti C. L., Gassmann M. and Hermann D. M. (2005) Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. Neurol. 19, 249251.
  • Kisseleva T., Bhattacharya S., Braunstein J. and Schindler C. W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285, 124.
  • Konishi Y., Chui D. H., Hirose H., Kunishita T. and Tabira T. (1993) Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro, in vivo. Brain Res. 609, 2935.
  • Kulich S. M. and Chu C. T. (2001) Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J. Neurochem. 77, 10581066.
  • Larsen K. E., Fon E. A., Hastings T. G., Edwards R. H. and Sulzer D. (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 22, 89518960.
  • Lee J. Y., Koh H. C., Chang M. Y., Park C. H., Lee Y. S. and Lee S. H. (2003) Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors. Neuroreport 14, 14011404.
  • Leist M., Ghezzi P., Grasso G. et al. (2004) Derivatives of erythropoietin that are tissue protective but not erythropoeitic. Science 305, 239242.
  • Liang Q. H., Liou A. K. F., Ding Y. M., Cao G. D., Xiao X., Perez R. G. and Chen J. (2004) 6-hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression. J. Neurosci. Res. 77, 747761.
  • Liou A. K., Clark R. S., Henshall D. C., Yin X. M. and Chen J. (2003) To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Prog. Neurobiol. 69, 103142.
  • Lotharius J., Dugan L. L. and O'Malley K. L. (1999) Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J. Neurosci. 19, 12841293.
  • Macdougall I. C., Matcham J., Gray S. J. and Grp N. S. (2003) Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis. Nephrol. Dial. Transpl. 18, 576581.
  • Maiese K., Li F. Q. and Chong Z. Z. (2004) Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol. Sci. 25, 577583.
  • Marti H. H. (2004) Erythropoietin and the hypoxic brain. J. Exp. Biol. 207, 32333242.
  • Masuda S., Okano M., Yamagishi K., Nagao M., Ueda M. and Sasaki R. (1994) A novel site of erythropoietin production–oxygen-dependent production in cultured rat astrocytes. J. Biol. Chem. 269, 19 48819 493.
  • Nair V. D., Olanow C. W. and Sealfon S. C. (2003) Activation of phosphoinositide 3-kinase by D-2 receptor prevents apoptosis in dopaminergic cell lines. Biochem. J. 373, 2532.
  • Ochu E. E., Rothwell N. J. and Waters C. M. (1998) Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells. J. Neurochem. 70, 26372640.
  • Oh Y. J., Wong S. C., Moffat M. and O'Malley K. L. (1995) Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line. Neurobiol. Dis. 2, 157167.
  • Rao R. V., Hermel E., Castro-Obregon S., Del Rio G., Ellerby L. M., Ellerby H. M. and Bredesen D. E. (2001) Coupling endoplasmic reticulum stress to the cell death program – Mechanism of caspase activation. J. Biol. Chem. 276, 3386933874.
  • Romashkova J. A. and Makarov S. S. (1999) NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 8690.
  • Ryu E. J., Harding H. P., Angelastro J. M., Vitolo O. V., Ron D. and Greene L. A. (2002) Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22, 10 69010 698.
  • Salinas M., Diaz R., Abraham N. G., De Galarreta C. M. R. and Cuadrado A. (2003) Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278, 13 89813 904.
  • Sättler M. B., Merkler D., Maier K., Stadelmann C., Ehrenreich H., Bahr M. and Diem R. (2004) Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis, in Cell Death Differ 1, S181S192.
  • Shingo T., Sorokan S. T., Shimazaki T. and Weiss S. (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21, 97339743.
  • Siren A. L., Fratelli M., Brines M. et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl Acad. Sci. USA 98, 40444049.
  • Son J. H., Chun H. S., Joh T. H., Cho S., Conti B. and Lee J. W. (1999) Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos. J. Neurosci. 19, 1020.
  • Stanciu M., Wang Y., Kentor R. et al. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275, 12 20012 206.
  • Stocchi F. and Olanow C. W. (2003) Neuroprotection in Parkinson's disease: clinical trials. Ann. Neurol. 53, S87S97.
  • Studer L., Csete M., Lee S. H., Kabbani N., Walikonis J., Wold B. and McKay R. (2000) Enhanced proliferation, survival and dopaminergic differentiation of CNS precursors in lowered oxygen. J. Neurosci. 20, 73777383.
  • Tatton W. G., Chalmers-Redman R., Brown D. and Tatton N. (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann. Neurol. 53, S61S70.
  • Tomac A., Lindqvist E., Lin L. F. H., Ogren S. O., Young D., Hoffer B. J. and Olson L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335339.
  • Ugarte S. D., Lin E., Klann E., Zigmond M. J. and Perez R. G. (2003) Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J. Neurosci. Res. 73, 105112.
  • Xia Z. G., Dickens M., Raingeaud J., Davis R. J. and Greenberg M. E. (1995) Opposing effects of Erk and Jnk-P38 Map kinases on apoptosis. Science 270, 13261331.
  • Zhang L., Schallert T., Zhang Z. G., Jiang Q., Arniego P., Li Q. J., Lu M. and Chopp M. (2002) A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Meth. 117, 207214.